Joachim Lütken Weischenfeldt

Joachim Lütken Weischenfeldt

Group leader, Clinical Professor

Member of:

    ORCID: 0000-0002-3917-5524

    Publication year:
    All
    1 - 3 out of 3Page size: 10
    1. 2021
    2. Published

      Mutations known from B-cell lymphoid malignancies are not found in CD34+ stem cells from patients with lymphoma

      Husby, Simon, Favero, Francesco, Rodriguez Gonzalez, Francisco G, Sutton, L. A., Haastrup, E. K., mxz703, mxz703, Hansen, Jakob Werner, Arboe, B., Aslan, D., Clasen-Linde, E., Gjerdrum, Lise Mette Rahbek, Gørlev, J. S., Brown, Peter de Nully, Fischer-Nielsen, A., Rosenquist, R., Weischenfeldt, Joachim Lütken & Grønbæk, Kirsten, 2021, In: Leukemia and Lymphoma. 62, 11, p. 2808-2811

      Research output: Contribution to journal › Journal article › Research › peer-review

    3. Published

      Systematic dissection of transcriptional regulatory networks by genome-scale and single-cell CRISPR screens

      Lopes, R., Sprouffske, K., Sheng, C., Uijttewaal, E. C. H., Wesdorp, A. E., Dahinden, J., Wengert, S., Diaz-Miyar, J., Yildiz, U., Bleu, M., Apfel, V., Mermet-Meillon, F., Krese, R., Eder, M., Olsen, A. V., Hoppe, P., Knehr, J., Carbone, W., Cuttat, R., Waldt, A. & 8 others, Altorfer, M., Naumann, U., Weischenfeldt, Joachim Lütken, deWeck, A., Kauffmann, A., Roma, G., Schübeler, D. & Galli, G. G., 2021, In: Science Advances. 7, 27, eabf5733.

      Research output: Contribution to journal › Journal article › Research › peer-review

    4. Published

      TET2 mutations are associated with hypermethylation at key regulatory enhancers in normal and malignant hematopoiesis

      Tulstrup, Morten Rytter, Soerensen, M., Hansen, Jakob Werner, Gillberg, Linn, Needhamsen, M., Kaastrup, K., Helin, K., Christensen, K., Weischenfeldt, Joachim Lütken & Grønbæk, Kirsten, 2021, In: Nature Communications. 12, 1, 10 p., 6061.

      Research output: Contribution to journal › Journal article › Research › peer-review

    ID: 3997200